临床结果评估可能是支持炎性肠病临床实践的更有用工具,而不仅仅是患者报告的结果措施
Nagesh Kamat1, Gaurav Patil1, Ankit Dalal1
1Institute of Gastrosciences, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, India.
Current medical research and opinion
|July 18, 2025
概括
在炎症性肠病中,患者报告的结果措施 (PROM) 可能由于患者偏见和社会可取性而不可靠. 整合临床医生评估提供了更准确的反映疾病活动.
科学领域:
- 胃肠病学 胃肠病学
- 临床研究 临床研究
- 患者报告的结果
背景情况:
- 炎症性肠病 (IBD) 患者表现出各种症状,对评估提出了挑战.
- 患者报告的结果测量 (PROM) 是至关重要的,但在准确性和通用性方面存在局限性.
- 患者可能不充分报告症状或提供社会上可取的反应,影响数据可靠性.
研究的目的:
- 评估PROM在评估IBD疾病活动中的局限性.
- 突出患者调查中错误报告的可能性.
- 倡导整合临床结果评估.
主要方法:
- 在研究调查和PROM中分析影响患者反应的因素.
- 检查患者可能隐或改变信息的动机.
- 审查调查设置对响应准确性的影响.
主要成果:
- 由于患者不愿透露敏感信息或他们倾向于社会上理想的反应,PROM数据可能会有偏见.
- 匿名性并不能保证真实报道,因为患者可能仍然会怀疑所需的答案.
- 单独的PROM可能不足以准确反映IBD疾病的严重程度或活性.
结论:
- 仅仅依靠PROM进行IBD评估可能会导致严重的错误报告.
- 需要灵活的终点,包括客观的临床观察和评估.
- 将临床结果评估与PROM相结合,对于全面了解IBD至关重要.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
424
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
424
Inflammatory Bowel Disease II: Crohn's Disease
390
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
390
Inflammatory Bowel Disease I: Ulcerative Colitis
329
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
329
Inflammatory Bowel Disease IV: Pharmacological Management
196
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
196
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
250
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
250
Inflammatory Bowel Disease V: Surgical Management
219
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
219


